Artesian Therapeutics Inc.
www.artesianrx.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Artesian Therapeutics Inc.
Deal Watch: Shire, Allergan Move To Shore Up Core Franchises
Bristol acquires Cardioxyl and its Phase II congestive heart failure candidate as the latest deal to firm up its specialty drug pipeline, while Sanofi inks a cancer immunotherapy deal with BioNTech and a pair of diabetes-related partnerships with Hanmi and Lexicon.
Selected Start-Ups (12/02)
In Vivo briefly summarizes the technologies of these recently founded companies: Artesian Therapeutics Inc., Dynogen Pharmaceuticals Inc., GeneCraft Inc., MRI Cardiac Services Inc., Threshold Pharmaceuticals Inc. and ZuChem Inc.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice